FDA NDC Directory · JSON-LD · Markdown

ADMELOG

NDC 0024-5926 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameinsulin lispro
Labeler / ManufacturerSanofi-Aventis U.S. LLC
Marketing categoryBiologic License Application · App BLA209196
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsINSULIN LISPRO (100 U/mL)
Marketing started20181019
Package count1

External sources

Source: openFDA. Public-domain (CC0).